Elekta AB (publ) Stock

Elekta AB (publ) serves as an international medical technology company. It engages in the development and marketing of treatment solutions and equipment for use within radiation oncology and neurosurgery. Elekta’s systems and solutions are used at approximately 2,000 hospitals around the world to treat cancer and to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders. The company offers different clinical solutions in Precision Radiation Therapy, Image Guided Radiation Therapy, Stereotactic Radiation Therapy, Gamma Knife surgery, Stereotactic Neurosurgery and Functional Mapping.

Products

Elekta Synergy is a digital linear accelerator, equipped with an integrated solution for resolution, three dimensional images of the patient’s soft tissue taken in the treatment position at the time of treatment. The system can operate in PlanarView (2D images), MotionView (sequential images) and VolumeView (3D images). These images make it possible to see also soft tissue, such as tumors and sensitive organs.

Elekta Precise offers a system for radiation therapy, which has been specifically designed to be easily integrated with other systems. The system also supports radiation therapy techniques, such as intensity modulated radiation therapy (IMRT).

In addition to offering the linear accelerators Elekta Precise and Elekta Synergy, Elekta also supplies a range of accessory products for treatment and workflow.

The OmniWedge combines the use of a universal wedge, virtual wedge and open field to produce a wedged field in any orientation and allows the user to achieve a precise fit without wedge orientation becoming a limiting factor.

Elekta also offers iViewGT, a portal imaging system, which can register the patient’s position in relation to the radiation field during treatment.

PrecisePLAN is a solution for threedimensional and IMRT dose planning. This is one of a number of Elekta solutions that integrate and thereby increase efficiency in the planning of cancer treatment.

Desktop Pro is the integrated linear accelerator recording and verification control system, which simplifies the department’s administration of patient, clinical and treatment data.

The network software solution, PreciseNET, integrates the entire workflow within the hospital from activities in the radiation therapy department to the hospital’s information management and archiving tools.

The company offers Leksell Stereotactic System, a three-dimensional stereotactic localization system, which is attached to the patient's head; and is used to facilitate minimally invasive brain surgery. It offers the Precise Treatment System - with digital linear accelerator, patient table, and a registration system; Leksell Gamma Knife, a gentle form of treatment for the patient with out opening the skull; and intensity modulated radiotherapy. Leksell Gamma Knife is used for treatment of vascular malformations, benign tumors, metastases and other malignant tumors, as well as functional disorders.

The company also offers Precise Table, Stereotactic Body Frame, Active Breathing Coordinator, Desktop, PrecisePLAN, Leksell GammaPlan, Leksell SurgiPlan, Stereotactic Guide, Brain Atlas, and Neuromag Vectorview. It launched Elekta MicroDrive as an integrated part of Leksell Stereotactic System, designed to find the optimal electrode position for treatment of certain functional disorders. The development of Elekta Synergy S is a result of Elekta’s commitment to cross-fertilize the areas of radiation therapy and neurosurgery. The company has also developed components, such as disposable biopsy needles and fixation screws. Elekta Neuromag is a magnetoencephalograph, a diagnostic system, which registers nerve cell activity in the brain in real time.

Support services

Elekta also provides customer support services, such as training and finance. The company offers both traditional financing forms through, export credits or various leasing products and fee-for-use arrangements. Customer financing is arranged through banks, leasing companies and other external parties, such as development banks and international aid agencies.

Market

The primary markets for Elekta’s products are Europe and North America, followed by Asia and Japan. It has subsidiaries in 16 countries.

Significant Events

The company has formed an investment company, Global Medical Investments with Swedfund International AB for financing and establishment of cancer care projects in developing countries. Global Medical Investments, GMI, would invest, develop and support the establishment of cancer management programs in developing countries across the world in cooperation with local healthcare providers and partners.

History

Elekta AB (publ) was founded in 1972 by the Lars Leksell.